Navigation Links
Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued
Date:1/5/2011

PALO ALTO, Calif., Jan. 5, 2011 /PRNewswire/ -- Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee.   Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.

"Hydros and Hydros TA are designed to offer patients suffering from knee osteoarthritis more effective and safer options for managing the pain associated with their disease, and potentially, may help to delay knee replacement surgery," said George Daniloff, President and CEO of Carbylan BioSurgery.  "Carbylan's polymer technology platform uniquely enables products we believe are superior to existing viscosupplement technology."

The COR1.0 clinical trial is being conducted at eight clinical sites in Canada, Belgium, and The Netherlands.  The trial is designed to evaluate the safety and efficacy of Hydros and Hydros TA compared with Synvisc-One®, the market leading viscosupplement.  A total of 98 patients have been treated in the study and will be followed for six months post injection.  Carbylan expects final results from the study in August 2011, with pivotal studies for FDA approval expected to follow.

"We are very pleased that patient enrollment in the COR1.0 study was completed ahead of schedule. We believe this reflects the high level of interest in our product concept from both physicians and patients," commented Marcee Maroney, Vice President of Clinical Affairs and Marketing at Carbylan.   "There is a clear clinical need for a safe, fast-acting, long lasting therapy to treat the pain associated with osteoarthritis of the knee.  We believe that Hydros and Hydros TA are particularly well positioned to address this need."

In addition, Carbylan announced that
'/>"/>

SOURCE Carbylan BioSurgery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boston Scientific Completes Acquisition of Sadra Medical
2. SRI International Completes Integration of Sarnoff Corporation
3. Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific
4. Boston Scientific Completes Sale of Neurovascular Business
5. Henry Schein Completes Acquisition of Provet Holdings Limited
6. Hanger Orthopedic Group, Inc. Completes Exchange Offer of 7 1/8% Senior Notes Due 2018
7. WebMD Completes Redemption of 3 1/8% Convertible Notes
8. Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
9. Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride)
10. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
11. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 25, 2015 Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ... by Technology, Imaging and by Application - Forecast to 2020" ... is expected to reach $13.1 Billion in 2020 from an estimated ... The market is dominated by North America ... , and Rest of the World (RoW). The cancer diagnostics ...
(Date:7/2/2015)... Mass. , July 2, 2015   ... and European retinal specialists identify less frequent dosing ... edema (DME), due to the burden on both ... anti-vascular endothelial growth factor (VEGF) injections, which are ... Allergan/Molecular Partners, abicipar pegol, which is in development ...
(Date:7/2/2015)... 2015 BGI gab heute bekannt, ... vom American College of Pathologists (CAP) akkreditiert ... erste klinische Next-Generation-Sequencing Labor, das in ... und somit die höchsten Standards an klinischer ... FDA - 21 CFR Part 11 konformen ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
... MOUNTAIN VIEW, Calif., April 28, 2011 IRIDEX Corporation (NASDAQ: ... quarter 2011 financial results after the market closes on ... the Company will host a conference call with the investment community ... Thursday, May 5, 2011 to discuss the results ...
... April 28, 2011 PharmaNet Development Group, Inc., a ... generic drug and medical device companies, announced today that ... President, Corporate Quality Assurance. "We are ... Newman, MD, President, PharmaNet Development Group. "Valerie brings deep ...
Cached Medicine Technology:
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... New Albany, MS 38652, will have a grand opening event on July 4, 2015 ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on ... opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association of ... the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together ... seeks to decrease drug overdose – especially of heroin and opioid medication – ...
(Date:7/2/2015)... Lincoln, RI (PRWEB) , ... July 02, 2015 , ... ... keep safety in mind. That’s why Amica Insurance is sharing some tips ... Safety Commission (CPSC), approximately 230 people go to the emergency room daily with fireworks-related ...
(Date:7/2/2015)... , ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift ... alone. He sat down to write his first poem, and three years later he was ... was special and worth sharing with the world. "I have always believed that the best ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... PRESSURE DOES NOT PREDICT EFFECT ON HEART IN CHILDREN // ... lead to a potentially dangerous enlargement of the heart, according ... Hopkins Children's Center and the Children's Hospital at Montefiore in ... children, at least, that the higher the blood pressure the ...
... with Actonel are more likely to sustain when ... in the peer-reviewed journal Osteoporosis International after collecting ... ,The study of 33,000 postmenopausal women showed that ... most popular osteoporosis treatments, patients taking Actonel? (risedronate ...
... Support to Primary Education (commonly known as Mid-Day Meal ... the world //covering nearly 12 crore children in more ... Innovative Education (AIE) centers. ,The scheme provides ... and 12 gms of protein. The Scheme has been ...
... conducted a survey on “Man Flu”. "Man flu," is that mysterious ... barely seem to affect their female counterparts, " according to Nuts, ... per cent of men had Flu, that forced them to stay ... cent of women said the same. The survey also revealed that ...
... exercise works well for weight loss, but dieters end up ... want to lose weight in their 50s and 60s, to ... calories. ,Both, those who dieted and those who ... from the study on ‘whether a calorie-restriction diet can extend ...
... the stigma of the disease. // ,According to official ... to 1.56 percent in 2005, from 14.7 percent in 2001. ... cured are called, have been roped in since leprosy is on ... Ranchi has gone up to 1.60 percent between April and August, ...
Cached Medicine News:Health News:Children and Chronic Kidney Disease 2Health News:Children and Chronic Kidney Disease 3Health News:Actonel Treats Hip Fractures In A Better Way Than Alendronate 2Health News:Mid-Day Meal Scheme Catches on in India 2Health News:Which Is Better For Losing Weight? - Diet Or Exercise 2
The HEP-3, with a transfer area of 35cmW x 45cmL, is designed specifically for the transfer of nucleic acids from sequencing gels to nylon membranes....
... electrophoretic transfer cell and PowerPac 200 ... Transfers. Minimal Buffer Requirements. ... Reliable Transfers. Single-Step Locking System ... to Transfer Multiple Gels. New ...
PosiBlot 30-30 Sponges...
Ice block will provide sufficient cooling for most normal blotting applications. Sealed block is held submerged in transfer buffer. Ice block will not spill during refreezing....
Medicine Products: